Breast cancer genomes - form and function

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

This review summarizes advances in our understanding of the genomic and epigenomic abnormalities in breast cancers that are being revealed by the increasingly powerful suite of genomic analysis technologies. It summarizes the remarkable genomic heterogeneity that characterizes the disease, describes mechanisms that shape cancer genomes as they evolve toward metastasis, summarizes important recurrent aberrations that exist in spite of the genomic chaos and that contribute to breast cancer pathophysiology, and describes the use of preclinical models to identify drugs that will be effective against subsets of breast cancers carrying specific genomic and epigenomic abnormalities.

Original languageEnglish (US)
Pages (from-to)4-14
Number of pages11
JournalCurrent Opinion in Genetics and Development
Volume20
Issue number1
DOIs
StatePublished - Feb 2010
Externally publishedYes

Fingerprint

Genome
Breast Neoplasms
Epigenomics
Neoplasm Metastasis
Technology
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Breast cancer genomes - form and function. / Korkola, James; Gray, Joe.

In: Current Opinion in Genetics and Development, Vol. 20, No. 1, 02.2010, p. 4-14.

Research output: Contribution to journalArticle

@article{f48c92c2473a49f0afd728a01ed00a83,
title = "Breast cancer genomes - form and function",
abstract = "This review summarizes advances in our understanding of the genomic and epigenomic abnormalities in breast cancers that are being revealed by the increasingly powerful suite of genomic analysis technologies. It summarizes the remarkable genomic heterogeneity that characterizes the disease, describes mechanisms that shape cancer genomes as they evolve toward metastasis, summarizes important recurrent aberrations that exist in spite of the genomic chaos and that contribute to breast cancer pathophysiology, and describes the use of preclinical models to identify drugs that will be effective against subsets of breast cancers carrying specific genomic and epigenomic abnormalities.",
author = "James Korkola and Joe Gray",
year = "2010",
month = "2",
doi = "10.1016/j.gde.2009.11.005",
language = "English (US)",
volume = "20",
pages = "4--14",
journal = "Current Opinion in Genetics and Development",
issn = "0959-437X",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Breast cancer genomes - form and function

AU - Korkola, James

AU - Gray, Joe

PY - 2010/2

Y1 - 2010/2

N2 - This review summarizes advances in our understanding of the genomic and epigenomic abnormalities in breast cancers that are being revealed by the increasingly powerful suite of genomic analysis technologies. It summarizes the remarkable genomic heterogeneity that characterizes the disease, describes mechanisms that shape cancer genomes as they evolve toward metastasis, summarizes important recurrent aberrations that exist in spite of the genomic chaos and that contribute to breast cancer pathophysiology, and describes the use of preclinical models to identify drugs that will be effective against subsets of breast cancers carrying specific genomic and epigenomic abnormalities.

AB - This review summarizes advances in our understanding of the genomic and epigenomic abnormalities in breast cancers that are being revealed by the increasingly powerful suite of genomic analysis technologies. It summarizes the remarkable genomic heterogeneity that characterizes the disease, describes mechanisms that shape cancer genomes as they evolve toward metastasis, summarizes important recurrent aberrations that exist in spite of the genomic chaos and that contribute to breast cancer pathophysiology, and describes the use of preclinical models to identify drugs that will be effective against subsets of breast cancers carrying specific genomic and epigenomic abnormalities.

UR - http://www.scopus.com/inward/record.url?scp=76049123509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76049123509&partnerID=8YFLogxK

U2 - 10.1016/j.gde.2009.11.005

DO - 10.1016/j.gde.2009.11.005

M3 - Article

C2 - 20060285

AN - SCOPUS:76049123509

VL - 20

SP - 4

EP - 14

JO - Current Opinion in Genetics and Development

JF - Current Opinion in Genetics and Development

SN - 0959-437X

IS - 1

ER -